查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
近視和老花眼治療市場：按疾病類型、治療類型和地區劃分 - 市場規模、份額、展望、機會分析，2023-2030 年
市場調查報告書
商品編碼
1350277

近視和老花眼治療市場：按疾病類型、治療類型和地區劃分 - 市場規模、份額、展望、機會分析，2023-2030 年

Myopia And Presbyopia Treatment Market, by Disease Type, by Treatment Type, and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2023年，全球近視和老花眼市場規模將達244億美元，預測期內（2023-2030年）複合年增長率為8.3%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 美國：244億美元
之前的數據 2018年至2021年 預測期 2023-2030
預測 2023-2030 年複合年增長率： 8.30% 2030年價值預測 427億美元
近視與老花眼治療市場-IMG1

老花眼和近視是描述眼睛功能障礙的術語。近視使人難以看清遠處的事物，而老花眼則使天然水晶體難以在近處和遠處的物體之間轉移焦點。老花眼在 40 歲至 50 歲之間出現。近視和老花眼的治療包括手術和藥物治療。也可以使用隱形眼鏡或框架眼鏡進行治療。近視和老花眼在世界各地變得越來越普遍。40歲以下族群視力喪失最常見的原因是近視，而老花眼是典型的與年齡相關的近距離聚焦能力下降。瞇眼、眼睛疲勞和頭痛是近視和老花眼的症狀。這些症狀可以透過眼鏡、隱形眼鏡和屈光手術來矯正和治療。此外，含藥眼藥水也是治療近視、老花眼的新方法。由於老花眼是一種與年齡相關的視力障礙，因此老年人口的增加是推動市場成長的關鍵因素之一。近視是 40 歲以下視力障礙最常見的原因，而老花眼是與年齡相關的近聚焦能力的正常下降。

市場動態

主要市場參與者不斷推出新產品和治療方法、合併和收購預計將推動全球近視和老花眼治療市場的成長。例如，2020 年 10 月 12 日，Eyenovia, Inc.（一家臨床階段的眼科生物製藥公司，開發微劑量陣列打印 (MAPTM) 療法的管道）及其全球眼保健業務 Bausch Health Companies Inc. 宣布， Bausch Health Companies Inc. 已獲得在美國和加拿大開發和商業化臨床顯微鏡列印的獨家許可。此實驗性阿托品製劑使用 Eyenovia, Inc. 的專有 Optejet 分配器技術進行給藥。

本研究的主要特點

  • 該研究報告對全球近視和老花眼治療市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030年）的市場規模和復合年增長率（CAGR）。
  • 它還強調了各個細分市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
  • 它還提供了有關市場驅動因素、限制因素、機會、新產品發布和批准、市場趨勢、區域前景、主要參與者採取的競爭策略等的重要見解。
  • 根據公司亮點、產品組合、主要亮點、業績和策略等參數對全球近視和老花眼治療市場的主要參與者進行了分析。
  • 本研究涵蓋的主要公司包括 ALCON Inc.、Bausch Health Companies Inc.、EssilorLuxottica (Essilor Ltd.)、Johnson & Johnson Vision、NIDEK CO. LTD.、Topcon Corporation、Zeimer Ophthalmic Systems AG 和 ZEISS International 等。
  • 該報告的見解使行銷人員和公司高管能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球近視和老花眼治療市場報告迎合了該行業的各個利益相關者，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
  • 利害關係人可以透過用於分析全球近視和老花眼治療市場的各種策略矩陣來促進他們的決策。

目錄

第一章 研究目的與前提

  • 研究目標
  • 先決條件
  • 縮略語

第二章 市場概況

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要
  • 連貫的機會地圖 (COM)

第三章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進者
    • 抑製劑
    • 市場機會
  • 影響分析
  • 近期產品發布
  • 流行病學
  • 合併、收購、聯盟
  • 監管場景
  • 重大發展
  • PEST分析

第四章 全球近視與老花眼治療市場：COVID-19 的影響分析

  • 經濟影響
  • COVID-19 的流行病學
  • 對供需的影響

第五章 全球近視與老花眼治療市場：依疾病類型劃分，2018-2030 年

  • 近視
  • 老花眼

第六章 全球近視與老花眼治療市場：依治療類型劃分，2018-2030 年

  • 處方鏡片
  • 隱形眼鏡
  • 手術
  • 藥物治療
  • 其他

第七章全球近視與老花眼治療市場：按地區劃分，2018-2030年

  • 北美
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 歐洲
  • 英國
  • 德國
  • 意大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東盟
  • 澳大利亞
  • 韓國
  • 亞太其他地區
  • 中東
  • 海灣合作委員會
  • 以色列
  • 其他中東
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第八章 競爭格局

  • ALCON Inc.
  • Bausch Health Companies Inc.
  • EssilorLuxottica（Essilor Ltd.）
  • Johnson &Johnson Vision
  • NIDEK CO. LTD.
  • Topcon Corporation
  • Zeimer Ophthalmic Systems AG
  • ZEISS International

第9章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI4206

The global myopia and presbyopia market is estimated to be valued at US$ 24.4 billion in 2023 and is expected to exhibit a CAGR of 8.3% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 24.4 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 8.30% 2030 Value Projection: US$ 42.7 Bn
Myopia And Presbyopia Treatment Market - IMG1

Presbyopia and myopia are terms used to describe eye dysfunction. Myopia makes it difficult to see objects in the distance, and presbyopia makes it difficult for the natural lens to shift its focus between near and far objects. Presbyopia affects people between the ages of 40 and 50. Surgery and medication are both options for treating myopia and presbyopia. Additionally, contact lenses or glasses can be used to treat these conditions. Myopia and presbyopia are becoming more common worldwide. The most frequent cause of vision impairment in people under the age of 40 is myopia (nearsightedness), whereas presbyopia is the typical age-related loss of near focusing ability. Squinting, eye strain, and headaches are signs of myopia and presbyopia. The conditions can be corrected or treated with eyeglasses, contact lenses, or refractive surgeries. Moreover, eye drops containing medication are also emerging treatments for myopia and presbyopia. Increasing geriatric population is one of the major factors driving the growth of the market, as presbyopia is an age-related visual impairment. Myopia (nearsighted) is the most common cause of impaired vision in people under the age of 40 while presbyopia is the normal loss of near focusing ability that occurs with age.

Market Dynamics

Increasing launches of new products,treatments, mergers, and acquisitions by key market players are expected to drive the global myopia and presbyopia treatment market growth. For instance, on October 12, 2020, Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company developing a pipeline of Microdose Array Print (MAPTM) therapeutics, and Bausch Health Companies Inc., its global eye health business, announced that an affiliate of Bausch Health Companies Inc. has acquired an exclusive license in the U.S. and Canada for the development and commercialization of an investigational microscopic print. This experimental atropine formulation is administered using Eyenovia, Inc. patented Optejet dispenser technology.

Key features of the study:

  • This report provides an in-depth analysis of the global myopia and presbyopia treatment market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global myopia and presbyopia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include ALCON Inc., Bausch Health Companies Inc., EssilorLuxottica (Essilor Ltd.), Johnson & Johnson Vision, NIDEK CO. LTD., Topcon Corporation, Zeimer Ophthalmic Systems AG, and ZEISS International
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global myopia and presbyopia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global myopia and presbyopia treatment market

Detailed Segmentation:

  • Global Myopia And Presbyopia Treatment Market, By Disease Type:
    • Myopia
    • Presbyopia
  • Global Myopia And Presbyopia Treatment Market, By Treatment Type:
    • Prescription Lenses
    • Contact Lenses
    • Surgery
    • Medication
    • Others
  • Global Myopia And Presbyopia Treatment Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
    • ALCON Inc.
    • Bausch Health Companies Inc.
    • EssilorLuxottica (Essilor Ltd.)
    • Johnson & Johnson Vision
    • NIDEK CO. LTD.
    • Topcon Corporation
    • Zeimer Ophthalmic Systems AG
    • ZEISS International

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Disease Type
    • Market Snapshot, By Treatment Type
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaboration
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Myopia And Presbyopia Treatment Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Myopia And Presbyopia Treatment Market, By Disease Type, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Myopia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Presbyopia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Global Myopia And Presbyopia Treatment Market, By Treatment Type, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Prescription Lenses
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Contact Lenses
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Medication
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Myopia And Presbyopia Treatment Market, By Region, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • ALCON Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bausch Health Companies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • EssilorLuxottica (Essilor Ltd.)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson Vision
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NIDEK CO. LTD.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Topcon Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zeimer Ophthalmic Systems AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ZEISS International
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us